Overview
Lobbying Costs
10,000€
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
corlife
EU Transparency Register
169673727443-86 First registered on 09 Jun 2017
Goals / Remit
Corlife entwickelt und produziert am Firmensitz in Hannover innovative Produkte für die Herzchirurgie. Das Hauptaugenmerk liegt dabei auf zellfreien, regenerativen Gewebeimplantaten, die vor allem bei der Korrektur angeborener Herzfehler angewendet werden.
Main EU files targeted
Stakeholder consultation for the evaluation of eu legislation on blood, tissues and cells. Participation in the Commissions public consultation on a new regulation on standards of quality and safety for substances of human origin intended for human application (Soho). corlife gave feedback to the commissions adoption under the umbrella of the organisation BPI on 31.08.2022.
Address
Head Office
Feodor-Lynen-Str. 23
Hannover 30625
GERMANYEU Office
Feodor-Lynen-Str. 23
Hannover 30625
GERMANYWebsite
-
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
The German Pharmaceutical Industry Association (BPI) represents the interests of around 260 pharmaceutical and biotech companies in Germany with approximately 70,000 employees: start-ups, SMEs and multinational companies. www.bpi.de
The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent. BPI is member of the EUCOPE (www.eucope.org)Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
10,000€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
0€ - 10,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
On 10.10.2023 the BPI had a meeting with EU parlamentarians ( Lena Düpont / EVP, CDU and Rasmus Andresen / Freie Europäische Allianz, Grüne) in Brussels concerning the SoHo regulation. For this meeting also corlife was invited and had been able to discuss about this topic with the parlamentarians.
Other activities
nein
Meetings
Meetings
None declared